DRAVET SYNDROME FOUNDATION INC: Form 990, tax year 2022
View the entire original 990 at ProPublica ↗
- Organization
- DRAVET SYNDROME FOUNDATION INC (EIN 27-0924627)
- Tax period
- 2022-01-01 to 2022-12-31
- Filed
- 2023-04-17
- IRS object ID
- 202301089349300125
- Schema version
- 2022v5.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2023-04-17T14:28:37-07:00 | ReturnTs |
| Tax Period End | 2022-12-31 | TaxPeriodEndDt |
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2022-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 270924627 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | DRAVET SYNDROME FOUNDATION INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | DRAV | BusinessNameControlTxt |
| Phone | 2033921955 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | PO Box 3026 | AddressLine1Txt |
| City | Cherry Hill | CityNm |
| State Abbreviation | NJ | StateAbbreviationCd |
| ZIP | 08034 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | Ted Odlaug | PersonNm |
| Person Title | President | PersonTitleTxt |
| Phone | 2033921955 | PhoneNum |
| Signature | 2023-04-17 | SignatureDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | Yes (1) | IRSResponsiblePrtyInfoCurrInd |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 1 | TrustedCustomerCd |
| OOB Security Verification | 11 | OOBSecurityVerificationCd |
| Last Submission Rqr OOB | 1 | LastSubmissionRqrOOBCd |
| Authentication Assurance Level | AAL2 | AuthenticationAssuranceLevelCd |
| Profile Password Change | Yes (X) | ProfilePasswordChangeInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2022 | TaxYr |
| Build TS | 2023-04-26 12:10:37Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | Ted Odlaug | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | PO Box 3026 | AddressLine1Txt |
| City | Cherry Hill | CityNm |
| State Abbreviation | NJ | StateAbbreviationCd |
| ZIP | 08034 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $2,733,455 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.dravetfoundation.org | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2009 | FormationYr |
| Legal Domicile State | CT | LegalDomicileStateCd |
| Activity Or Mission | The mission of the Dravet Syndrome Foundation is to aggressively raise funds for Dravet syndrome & related epilepsies; support & fund research; increase awareness; & provide support to affected individuals & families. | ActivityOrMissionDesc |
| Voting Members Governing Body | 8 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 8 | VotingMembersIndependentCnt |
| Total Employee | 7 | TotalEmployeeCnt |
| Total Volunteers | 50 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $1,437,446 | PYContributionsGrantsAmt |
| CY Contributions Grants | $1,713,227 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $693,507 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $662,596 | CYProgramServiceRevenueAmt |
| PY Investment Income | $5,151 | PYInvestmentIncomeAmt |
| CY Investment Income | $88,364 | CYInvestmentIncomeAmt |
| PY Other Revenue | $49,908 | PYOtherRevenueAmt |
| CY Other Revenue | $51,595 | CYOtherRevenueAmt |
| PY Total Revenue | $2,186,012 | PYTotalRevenueAmt |
| CY Total Revenue | $2,515,782 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $444,058 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $693,698 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $468,578 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $503,705 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $79,018 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $352,687 | PYOtherExpensesAmt |
| CY Other Expenses | $831,436 | CYOtherExpensesAmt |
| PY Total Expenses | $1,265,323 | PYTotalExpensesAmt |
| CY Total Expenses | $2,028,839 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $920,689 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $486,943 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $5,918,927 | TotalAssetsBOYAmt |
| Total Assets EOY | $6,249,148 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $592,323 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $488,374 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $5,326,604 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $5,760,774 | NetAssetsOrFundBalancesEOYAmt |
| Mission | The mission of the Dravet Syndrome Foundation is to aggressively raise funds for Dravet syndrome & related epilepsies; support & fund research; increase awareness; & provide support to affected individuals & families. We understand the ongoing need to fund innovative research, the urgency in finding better treatments, the motivation of our donors to make an impact specifically in the fields of Dravet syndrome and related epilepsies, the importance of transparency and accountability of not only our organization, but the researchers that we fund, and the need for global collaboration in order to find a cure. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $852,551 | ExpenseAmt |
| Grant | $667,345 | GrantAmt |
| Revenue | $10,000 | RevenueAmt |
| Desc | DSF funds research for better treatments and a cure for Dravet syndrome and related epilepsies by awarding research grants to qualified scientists and clinicians. These grants fund initial research hypotheses that have not been fully explored. The results extracted from this type of research will help bring untested research to the point that it can qualify for larger governmental funding. Since 2009, DSF has awarded over $6.4 million to 56 research endeavors. Research areas include SUDEP, gene therapy, drug discovery, screening, treatments, genetics, epidemiology and neuronal networks. In 2020, DSF hired a Scientific Director to serve as the liaison between the medical/scientific community and DSF, developing strategies to support research, manage DSF's involvement in projects, and move projects forward with assistance in project management, manuscript preparation, and other writing opportunities. The Scientific Director acts as a representative of DSF to other institutions including NIH, PDA, pharma and biotechnology companies. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $631,500 | ExpenseAmt |
| Grant | $26,353 | GrantAmt |
| Revenue | $503,096 | RevenueAmt |
| Desc | Receiving a diagnosis of Dravet syndrome (DS) can be overwhelming and may leave a family with many unanswered questions. DSF produces a biennial professional and family conference designed to unite community stakeholders to address these questions - families, caregivers, clinicians, researchers, and other professionals. Our 2022 conference welcomed over 300 parents, children and professionals. The 3-day event featured over 30 speakers who presented on current research, co-morbidities, best care practices, and daily living challenges. In 2017 the DSF Family Network was established to provide regional support to families. As part of this initiative, 5 educational workshops are held across the country on odd-numbered years, opposite of our biennial conference. These workshops are a time for patients and their families to come together to learn about research and treatment options, connect with others in their region, and be a part of DSF's shared vision for a better outcome for those affected by DS. In addition to these conferences and workshops, DSF has established an international patient assistance grant program to help patients receive medical equipment, therapy devices, and education aides associated with DS that are not covered through private insurance or other assistance programs. Since 2009, DSF has awarded over $222k in assistance to families. On February 3, 2022, DSF held an Externally-Led Patient-Focused Drug Development meeting on DS. This meeting was a long-awaited opportunity for our patient community to educate representatives of the FDA and pharmaceutical companies, as well as academic researchers and clinicians, about the challenges that individuals living with DS face daily. Our objective was to give patient families a platform to share what it means to have a DS diagnosis, which symptoms should be prioritized, and how this disease impacts the quality of life for the patient and family so that the FDA and pharmaceutical companies can understand the patient experience. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $154,497 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $149,500 | RevenueAmt |
| Desc | DSF produces an annual research roundtable meeting to provide opportunity for researchers and clinicians to collaborate and discuss better treatment options and a roadmap toward a cure and how to best facilitate both. This meeting started in 2010 as a brainstorming session for the few researchers working on Dravet syndrome (DS). DSF hosted its 13th annual Research Roundtable, and had our largest attendance yet, with over 200 participants. In 2022, DSF developed a professional education video series to highlight the latest guidelines in clinical care. The development of this updated professional educational series was prompted by the recent publication of the International Treatment Consensus on Diagnosis and Management of Dravet Syndrome. Also in 2022, DSF invited adult neurologists with an interest in learning more about DS to attend a meeting focused specifically on how to better support families through the transition from pediatric to adult care. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $0 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $0 | TotalOtherProgSrvcGrantAmt |
| Total Other Prog Srvc Revenue | $0 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $1,638,548 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | 0 | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | 0 | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | Yes (1) | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (1) | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | Yes (1) | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 13 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 7 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (1) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (1) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Form8899 Filedind | 0 | Form8899Filedind |
| Form1098 C Filed | 0 | Form1098CFiledInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 8 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 8 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | 0 | CompensationProcessCEOInd |
| Compensation Process Other | 0 | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Other Website | Yes (X) | OtherWebsiteInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | Jamie Cohen | PersonNm |
| Phone | 2033921955 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 522 Mackin Drive | AddressLine1Txt |
| City | Cherry Hill | CityNm |
| State Abbreviation | NJ | StateAbbreviationCd |
| ZIP | 08002 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (13 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd |
|---|---|---|---|---|---|---|---|---|
| Mary Anne Meskis | ||||||||
| Executive Director | 40 | 0 | Yes (X) | $155,000 | $0 | $0 | ||
| Veronica Hood | ||||||||
| Scientific Director | 40 | 0 | $151,200 | $0 | $0 | Yes (X) | ||
| Jamie Cohen | ||||||||
| Chief Financial Officer | 40 | 0 | Yes (X) | $88,560 | $0 | $0 | ||
| Kate Hintz | ||||||||
| President | 1 | 0 | Yes (X) | $0 | $0 | $0 | Yes (X) | |
| Ted Odlaug PhD | ||||||||
| Vice President | 1 | 0 | Yes (X) | $0 | $0 | $0 | Yes (X) | |
| Josh Goldman | ||||||||
| Treasurer | 1 | 0 | Yes (X) | $0 | $0 | $0 | Yes (X) | |
| Tim Wood | ||||||||
| Past Treasurer | 1 | 0 | Yes (X) | $0 | $0 | $0 | Yes (X) | |
| Ross Nicholas | ||||||||
| Secretary | 1 | 0 | Yes (X) | $0 | $0 | $0 | Yes (X) | |
| Nathan Batt | ||||||||
| Trustee | 1 | 0 | $0 | $0 | $0 | Yes (X) | ||
| Claire Carey | ||||||||
| Trustee | 1 | 0 | $0 | $0 | $0 | Yes (X) | ||
| Ashley Kerns | ||||||||
| Trustee | 1 | 0 | $0 | $0 | $0 | Yes (X) | ||
| Joseph Sullivan MD | ||||||||
| Trustee | 1 | 0 | $0 | $0 | $0 | Yes (X) | ||
| Jenny Tischer | ||||||||
| Past Trustee | 1 | 0 | $0 | $0 | $0 | Yes (X) | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $394,760 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $0 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 2 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp
Contractor Name ContractorName
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Geben Communication | BusinessNameLine1Txt |
Contractor Address ContractorAddress
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 143 E Main St 200 | AddressLine1Txt |
| City | Columbus | CityNm |
| State Abbreviation | OH | StateAbbreviationCd |
| ZIP | 43215 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Services | Public Relations | ServicesDesc |
| Compensation | $177,100 | CompensationAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 0 | CntrctRcvdGreaterThan100KCnt |
| Federated Campaigns | $0 | FederatedCampaignsAmt |
| Membership Dues | $0 | MembershipDuesAmt |
| Fundraising | $741,106 | FundraisingAmt |
| Related Organizations | $0 | RelatedOrganizationsAmt |
| Government Grants | $0 | GovernmentGrantsAmt |
| All Other Contributions | $972,121 | AllOtherContributionsAmt |
| Noncash Contributions | $0 | NoncashContributionsAmt |
| Total Contributions | $1,713,227 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | Unrelated Business RevenueUnrelatedBusinessRevenueAmt | ExclusionExclusionAmt |
|---|---|---|---|---|---|
| Professional Education & Meetings | 813319 | $149,500 | $149,500 | $0 | $0 |
| Research Grants | 813319 | $10,000 | $10,000 | $0 | $0 |
| Patient & Family Services | 813319 | $503,096 | $503,096 | $0 | $0 |
Total Oth Program Service Rev TotalOthProgramServiceRevGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $0 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $662,596 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $88,364 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $88,364 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $0 | ExclusionAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $0 | ExclusionAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $0 | SecuritiesAmt |
| Other | $0 | OtherAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $269,268 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $741,106 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $217,673 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $51,595 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $51,595 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $0 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $2,515,782 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $662,596 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $139,959 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $500,000 | TotalAmt |
| Program Services | $500,000 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $21,523 | TotalAmt |
| Program Services | $21,523 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $172,175 | TotalAmt |
| Program Services | $172,175 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $243,560 | TotalAmt |
| Program Services | $37,471 | ProgramServicesAmt |
| Management And General | $177,986 | ManagementAndGeneralAmt |
| Fundraising | $28,103 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $223,704 | TotalAmt |
| Program Services | $173,472 | ProgramServicesAmt |
| Management And General | $22,826 | ManagementAndGeneralAmt |
| Fundraising | $27,406 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $36,441 | TotalAmt |
| Program Services | $16,257 | ProgramServicesAmt |
| Management And General | $15,778 | ManagementAndGeneralAmt |
| Fundraising | $4,406 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,174 | TotalAmt |
| Management And General | $3,174 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,800 | TotalAmt |
| Management And General | $5,800 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $219,667 | TotalAmt |
| Program Services | $179,712 | ProgramServicesAmt |
| Management And General | $39,955 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,246 | TotalAmt |
| Program Services | $6,581 | ProgramServicesAmt |
| Management And General | $332 | ManagementAndGeneralAmt |
| Fundraising | $333 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $44,011 | TotalAmt |
| Program Services | $23,870 | ProgramServicesAmt |
| Management And General | $13,989 | ManagementAndGeneralAmt |
| Fundraising | $6,152 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $29,597 | TotalAmt |
| Program Services | $26,091 | ProgramServicesAmt |
| Management And General | $3,506 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $32,400 | TotalAmt |
| Program Services | $25,176 | ProgramServicesAmt |
| Management And General | $5,149 | ManagementAndGeneralAmt |
| Fundraising | $2,075 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $411,213 | TotalAmt |
| Program Services | $409,544 | ProgramServicesAmt |
| Management And General | $1,446 | ManagementAndGeneralAmt |
| Fundraising | $223 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,394 | TotalAmt |
| Program Services | $1,604 | ProgramServicesAmt |
| Management And General | $1,580 | ManagementAndGeneralAmt |
| Fundraising | $2,210 | FundraisingAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| Bank & Credit Card Processing Fees | $10,831 | $1,545 | $5,689 | $3,597 |
| Charity Registration Fees | $4,635 | $0 | $4,635 | $0 |
| Dues & Subscriptions | $16,002 | $2,061 | $9,428 | $4,513 |
| Other Expenses | $41,466 | $41,466 | $0 | $0 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,028,839 | TotalAmt |
| Program Services | $1,638,548 | ProgramServicesAmt |
| Management And General | $311,273 | ManagementAndGeneralAmt |
| Fundraising | $79,018 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $479,627 | BOYAmt |
| EOY | $560,961 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $947,112 | BOYAmt |
| EOY | $447,978 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $48,530 | BOYAmt |
| EOY | $54,682 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| EOY | $6,472 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $61,105 | BOYAmt |
| EOY | $11,792 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,382,553 | BOYAmt |
| EOY | $5,167,263 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,918,927 | BOYAmt |
| EOY | $6,249,148 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,702 | BOYAmt |
| EOY | $37,308 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $247,597 | BOYAmt |
| EOY | $299,923 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $340,024 | BOYAmt |
| EOY | $151,143 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $592,323 | BOYAmt |
| EOY | $488,374 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,225,375 | BOYAmt |
| EOY | $5,548,913 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $101,229 | BOYAmt |
| EOY | $211,861 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,326,604 | BOYAmt |
| EOY | $5,760,774 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,918,927 | BOYAmt |
| EOY | $6,249,148 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $486,943 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$52,773 | NetUnrlzdGainsLossesInvstAmt |
| Donated Services And Use Fclts | $0 | DonatedServicesAndUseFcltsAmt |
| Investment Expense | $0 | InvestmentExpenseAmt |
| Prior Period Adjustments | $0 | PriorPeriodAdjustmentsAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $1,459,444 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,609,408 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,228,571 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,437,446 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,713,227 | CurrentTaxYearAmt |
| Total | $7,448,096 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $1,459,444 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,609,408 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,228,571 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,437,446 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,713,227 | CurrentTaxYearAmt |
| Total | $7,448,096 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support Total170 | $7,448,096 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $523 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $42,174 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $16,250 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $5,151 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $88,364 | CurrentTaxYearAmt |
| Total | $152,462 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $7,600,558 | TotalSupportAmt |
| Public Support CY170 | 0.97994 | PublicSupportCY170Pct |
| Public Support PY170 | 0.99031 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $0 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $2,352,378 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$52,773 | NetUnrealizedGainsInvstAmt |
| Donated Services And Use Fclts | $0 | DonatedServicesAndUseFcltsAmt |
| Recoveries Prior Year Grants | $0 | RecoveriesPriorYearGrantsAmt |
| Other Revenue | $0 | OtherRevenueAmt |
| Revenue Not Reported | -$52,773 | RevenueNotReportedAmt |
| Revenue Subtotal | $2,405,151 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $0 | InvestmentExpensesNotIncldAmt |
| Other Revenues Not Included | $110,631 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | $110,631 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $2,515,782 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $2,028,839 | TotExpnsEtcAuditedFinclStmtAmt |
| Donated Services Use Fclts | $0 | DonatedServicesUseFcltsAmt |
| Prior Year Adjustments | $0 | PriorYearAdjustmentsAmt |
| Losses Reported | $0 | LossesReportedAmt |
| Other Expenses Included | $0 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $0 | ExpensesNotReportedAmt |
| Expenses Subtotal | $2,028,839 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $0 | InvestmentExpensesNotIncld2Amt |
| Other Expenses Not Included | $0 | OtherExpensesNotIncludedAmt |
| Expenses Not Rpt Fincl Stmt | $0 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $2,028,839 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Schedule D, Part X, Line 2 | DSF recognizes the effect of tax positions only when they are more than likely than not of being sustained. Management has determined that the foundation has no uncertain tax positions that would require financial statement recognition. Tax years dating back to 2019 remain open to examination by federal and state authorities. |
| Schedule D, Part XI, Line 4b | Change in net assets with donor restrictions |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (7 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|
| Europe (including Iceland and Greenland) | 0 | 0 | Grantmaking | $155,845 |
| North America (including Canada and Mexico, but not the United States) | 0 | 0 | Grantmaking | $5,427 |
| East Asia and the Pacific | 0 | 0 | Grantmaking | $3,403 |
| Sub-Saharan Africa | 0 | 0 | Grantmaking | $3,000 |
| Middle East and North Africa | 0 | 0 | Grantmaking | $1,500 |
| South America | 0 | 0 | Grantmaking | $1,500 |
| South Asia | 0 | 0 | Grantmaking | $1,500 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Total Spent | $172,175 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Region | Europe (including Iceland and Greenland) | RegionTxt |
| Purpose Of Grant | Use of TMS to Understand In-Vivo the Functional Pathophysiology of Dravet Syndrome and Predict Treatment Response- Dr. Balestrini and Dr. Sisodiya will work together on this collaborative effort to use transcranial magnetic stimulation (TMS) to characterize the brain activity patterns of patients with Dravet syndrome. They will compare changes in TMS to patient genotype, responses to treatments, cognitive abilities, and other common symptoms in Dravet syndrome. They will additionally use TMS to better understand how alterations in brain activity may change over time and with age in Dravet syndrome. | PurposeOfGrantTxt |
| Cash Grant | $149,845 | CashGrantAmt |
| Manner Of Cash Disbursement | Wire Transfer | MannerOfCashDisbursementTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 1 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
Foreign Individuals Grants ForeignIndividualsGrantsGrp (10 entries)
| Type Of AssistanceTypeOfAssistanceTxt | RegionRegionTxt | RecipientRecipientCnt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt | Non Cash AssistanceNonCashAssistanceAmt | Description Of Non Cash AsstDescriptionOfNonCashAsstTxt | Valuation Method UsedValuationMethodUsedDesc |
|---|---|---|---|---|---|---|---|
| Patient Assistance Grants. The DSF Patient Assistance Grant Program offers grants to patients with Dravet syndrome and related epilepsies for necessary medical equipment therapy devices, and educational aids associated with these conditions that are not covered through private insurance or other assistance programs. This program is open to all patients worldwide who are members of the DSF Family Network. | Europe (including Iceland and Greenland) | 1 | $1,500 | Wire Transfer | |||
| Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations. | Europe (including Iceland and Greenland) | 3 | $4,500 | Wire Transfer | |||
| Patient Assistance Grants. The DSF Patient Assistance Grant Program offers grants to patients with Dravet syndrome and related epilepsies for necessary medical equipment therapy devices, and educational aids associated with these conditions that are not covered through private insurance or other assistance programs. This program is open to all patients worldwide who are members of the DSF Family Network. | East Asia and the Pacific | 1 | $403 | Items that are currently covered under this program include: durable medical goods (such as wheelchairs, orthotics, cooling vests, etc.), therapy equipment, communication devices such as iPads, and costs associated with implementation of the ketogenic diet. By awarding these grants, DSF is making no recommendation to the appropriateness or safety of a particular piece of equipment or therapy in treating Dravet syndrome and associated epilepsies and conditions. DSF and its Board of Directors are not responsible for the safety and use of awarded equipment or therapies. Applicants are strongly urged to consult with their medical professionals and therapists regarding equipment and therapies that would be most beneficial for the situation. | FMV | ||
| Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations. | East Asia and the Pacific | 2 | $3,000 | Wire Transfer | |||
| Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations. | Middle East and North Africa | 1 | $1,500 | Wire Transfer | |||
| Patient Assistance Grants. The DSF Patient Assistance Grant Program offers grants to patients with Dravet syndrome and related epilepsies for necessary medical equipment therapy devices, and educational aids associated with these conditions that are not covered through private insurance or other assistance programs. This program is open to all patients worldwide who are members of the DSF Family Network. | North America (including Canada and Mexico, but not the United States) | 3 | $4,427 | Items that are currently covered under this program include: durable medical goods (such as wheelchairs, orthotics, cooling vests, etc.), therapy equipment, communication devices such as iPads, and costs associated with implementation of the ketogenic diet. By awarding these grants, DSF is making no recommendation to the appropriateness or safety of a particular piece of equipment or therapy in treating Dravet syndrome and associated epilepsies and conditions. DSF and its Board of Directors are not responsible for the safety and use of awarded equipment or therapies. Applicants are strongly urged to consult with their medical professionals and therapists regarding equipment and therapies that would be most beneficial for the situation. | |||
| Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations. | North America (including Canada and Mexico, but not the United States) | 1 | $1,000 | Wire Transfer | |||
| Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations. | South America | 1 | $1,500 | Wire Transfer | |||
| Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations. | South Asia | 1 | $1,500 | Wire Transfer | |||
| Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations. | Sub-Saharan Africa | 1 | $3,000 | Wire Transfer |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule F, Part I, Line 2 | FormAndLineReferenceDesc |
| Explanation | DSF provides funds for research. The organizations receiving this assistance are required to provide written progress reports on their research into finding a cure for Dravet syndrome and related epilepsies. The Scientific Director of DSF reviews the progress reports and discusses the research projects and progress with the awarded organization. DSF also provides funding to patients with Dravet syndrome and related epilepsies for necessary medical equipment, therapy devices and education aids associated with these conditions that are not covered through private insurance or other assistance programs. Applicants are required to submit an application that includes a recent letter from the child's healthcare provider explaining the medical necessity of the request and when possible, a letter of denial from the insurance provider. | ExplanationTxt |
Schedule G IRS990ScheduleG
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | Dance for Dravet | Event1Nm |
| Gross Receipts Event1 | $463,720 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $340,333 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $123,387 | GrossRevenueEvent1Amt |
| Cash Prizes Event1 | $0 | CashPrizesEvent1Amt |
| Non Cash Prizes Event1 | $0 | NonCashPrizesEvent1Amt |
| Rent Facility Costs Event1 | $26,528 | RentFacilityCostsEvent1Amt |
| Food And Beverage Event1 | $25,979 | FoodAndBeverageEvent1Amt |
| Entertainment Event1 | $2,050 | EntertainmentEvent1Amt |
| Other Direct Expenses Event1 | $16,605 | OtherDirectExpensesEvent1Amt |
| Event2 | Double Down for Dravet Houston | Event2Nm |
| Gross Receipts Event2 | $151,696 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $110,455 | CharitableContriEvent2Amt |
| Gross Revenue Event2 | $41,241 | GrossRevenueEvent2Amt |
| Cash Prizes Event2 | $0 | CashPrizesEvent2Amt |
| Non Cash Prizes Event2 | $0 | NonCashPrizesEvent2Amt |
| Rent Facility Costs Event2 | $4,763 | RentFacilityCostsEvent2Amt |
| Food And Beverage Event2 | $38,000 | FoodAndBeverageEvent2Amt |
| Entertainment Event2 | $3,599 | EntertainmentEvent2Amt |
| Other Direct Expenses Event2 | $8,897 | OtherDirectExpensesEvent2Amt |
| Other Events Total | 16 | OtherEventsTotalCnt |
| Gross Receipts Other Events | $394,878 | GrossReceiptsOtherEventsAmt |
| Charitable Contri Other Events | $290,238 | CharitableContriOtherEventsAmt |
| Gross Revenue Other Events | $104,640 | GrossRevenueOtherEventsAmt |
| Cash Prizes Other Events | $0 | CashPrizesOtherEventsAmt |
| Non Cash Prizes Other Events | $0 | NonCashPrizesOtherEventsAmt |
| Rent Fclty Costs Other Events | $2,336 | RentFcltyCostsOtherEventsAmt |
| Food And Beverage Other Events | $20,147 | FoodAndBeverageOtherEventsAmt |
| Entertainment Other Events | $8,585 | EntertainmentOtherEventsAmt |
| Oth Direct Expnss Other Events | $60,184 | OthDirectExpnssOtherEventsAmt |
| Gross Receipts Total | $1,010,294 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $741,026 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $269,268 | GrossRevenueTotalEventsAmt |
| Cash Prizes Total Events | $0 | CashPrizesTotalEventsAmt |
| Non Cash Prizes Total Events | $0 | NonCashPrizesTotalEventsAmt |
| Rent Fclty Costs Total Events | $33,627 | RentFcltyCostsTotalEventsAmt |
| Food And Beverage Total Events | $84,126 | FoodAndBeverageTotalEventsAmt |
| Entertainment Total Events | $14,234 | EntertainmentTotalEventsAmt |
| Oth Direct Expnss Total Events | $85,686 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $217,673 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | $51,595 | NetIncomeSummaryAmt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (4 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| The Regents of the University of Michigan | |||||||
| 3003 S State St | Ann Arbor | MI | 48109 | 386006309 | 501(c)(3) | $50,000 | Optimizing the Regional Administration of SCN8a-targeting RNAi Therapy- Dr. Yu's project worked to develop an AAV-delivery for a genetic-based therapy targeting the SCN8A gene. While the majority of cases of Dravet syndrome are caused by mutations in SCN1A, Dr. Yu and the Meisler lab have shown that using genetic-based therapies to reduce expression of the SCN8A gene can compensate for loss-of-function SCN1A-mutations that cause Dravet syndrome. |
| The Ohio State University | |||||||
| 1960 Kenny Road | Columbus | OH | 43210 | 316025986 | 501(c)(3) | $150,000 | Targeting Molecular Responses to Seizures in Dravet Syndrome- Dr. Wagnon's work previously identified that the gene Npas4 is reduced in a mouse model of Dravet syndrome. This project hypothesized that restoration of high Npas4 expression could ameliorate seizures and other symptoms using viral-mediated delivery of Npas4 to the brain of mice with SCN1A haploinsufficiency. |
| The Washington University | |||||||
| 700 Rosedale Avenue | St Louis | MO | 63112 | 430653611 | 501(c)(3) | $150,000 | Ketogenic Diet Modulated Brain Energy Metabolism in Dravet Syndrome- Dr. Thio and Dr. Garbow work together on this collaborative project to better understand the mechanisms whereby the ketogenic diet reduces seizures in Dravet syndrome. They will investigate two metabolic pathways in a genetic mouse model of Dravet syndrome and use neuroimaging techniques to assess these impacts within the brain. |
| University of Colorado Denver | |||||||
| 13001 E 17th Place Room W1124 | Aurora | CO | 80045 | 846000555 | 501(c)(3) | $150,000 | Lymphoblast Cell Lines as a Model to Uncover Metabolic Defects in Dravet Syndrome- Dr. Patel and Dr. Knupp work together on this collaborative project to establish lymphoblast cell lines from the blood of patients with Dravet syndrome and their unaffected siblings. This library of cell lines will then be used to investigate alterations in energy metabolism that may impact patients with Dravet syndrome as well as stand as a future resource for investigations of new drugs, diets, and treatment responses. |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 4 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (2 entries)
| Grant TypeGrantTypeTxt | RecipientRecipientCnt | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Valuation Method UsedValuationMethodUsedDesc | Non Cash AssistanceNonCashAssistanceDesc |
|---|---|---|---|---|---|
| Patient Assistance Grants. The DSF Patient Assistance Grant Program offers grants to patients with Dravet syndrome and related epilepsies for necessary medical equipment therapy devices, and educational aids associated with these conditions that are not covered through private insurance or other assistance programs. This program is open to all patients worldwide who are members of the DSF Family Network. The DSF Disaster Relief and Recovery Fund was established for patients with Dravet syndrome that have been impacted by natural and other significant natural disaster events in the U.S., such as tornados, hurricanes, earthquakes. Flooding that results from a significant natural disaster event would also qualify. Families that are members of the DSF Family network may apply for a $500 Visa card or Amazon E-card to be used for lodging, food supplies or however needed. | 27 | $4,015 | $16,008 | Fair Market Value | Items that are currently covered under this program include: durable medical goods (such as wheelchairs, orthotics, cooling vests, etc.), therapy equipment, communication devices such as iPads, and costs associated with implementation of the ketogenic diet. By awarding these grants, DSF is making no recommendation to the appropriateness or safety of a particular piece of equipment or therapy in treating Dravet syndrome and associated epilepsies and conditions. DSF and its Board of Directors are not responsible for the safety and use of awarded equipment or therapies. Applicants are strongly urged to consult with their medical professionals and therapists regarding equipment and therapies that would be most beneficial for the situation. |
| Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations. | 1 | $1,500 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule I, Part I, Line 2 | FormAndLineReferenceDesc |
| Explanation | DSF provides funds for research. The organizations receiving this assistance are required to provide written progress reports on their research into finding a cure Dravet syndrome and related epilepsies. The Scientific Director of DSF reviews the progress reports and discusses the research projects and progress with the awarded organization. DSF also provides funding to patients with Dravet syndrome and related epilepsies for necessary medical equipment, therapy devices and education aids associated with these conditions that are not covered through private insurance or other assistance programs. Applicants are required to submit an application that includes a recent letter from the child's healthcare provider explaining the medical necessity of the request and when possible, a letter of denial from the insurance provider. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (2 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mary Anne Meskis | ||||||||||||||
| Executive Director | $155,000 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $155,000 | $0 | $0 | $0 |
| Veronica Hood | ||||||||||||||
| Scientific Director | $151,200 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $151,200 | $0 | $0 | $0 |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Form 990, Part VI, Section B, Line 11b | A copy of Form 990 and all related schedules is provided to the executive committee of the board of directors for review prior to filing with the Internal Revenue Service. |
| Form 990, Part VI, Section B, Line 12c | A conflict of interest disclosures statement is distributed and signed by each board member annually. Conflicts are dealt with on a case-by-case basis. |
| Form 990, Part VI, Section C, Line 19 | DSF makes its governing documents and conflict of interest policy available to the public upon written request from the president. Financial statements are available for public view on the organization's website. |
| Form 990, Part IX, Line 11g | Other fees for services include Public Relations & Marketing ($172,600), Video Production ($28,450) Graphic Design ($6,163), Consulting ($4,250), Publishing ($3,950), Human Resource ($3,792) and Translation Services ($462). |
Comments